Takeda Announces Termination Of License Agreement For Tavocept(TM) In Japan
ASKA Pharmaceutical Co. Ltd. and Takeda Pharmaceutical Company Limited announced the termination of the License Agreement of March 15 2006 that had previously been entered into by Takeda ASKA KI Pharmaceuticals Inc.(*) and BioNumerik Pharmaceuticals Inc. with respect to the investigational new drug known as Tavocept(TM) for the territory of Japan. [click link for full article]
posted by Smile Community @ 12:09 AM
0 Comments:
Post a Comment
<< Home